Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic DermatitisEric L. Simpson, Ashish Bansal, David M. Pariser et al.|JAMA Dermatology|2019Cited by 505
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trialAmy S. Paller, Brad Shumel, Elaine C. Siegfried et al.|Journal of the American Academy of Dermatology|2020Cited by 385
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On StudyBrian P. Vickery, Dareen Siri, Andrea Vereda et al.|The Journal of Allergy and Clinical Immunology In Practice|2020Cited by 89
Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial ResultsJacqueline A. Pongracic, Philippe Bégin, Rémi Gagnon et al.|The Journal of Allergy and Clinical Immunology In Practice|2021Cited by 61